Why did this forgotten FTSE income share suddenly jump 21% in January?

Spirax Group is a top FTSE 100 income share, having hiked dividends for more than 50 years. It’s made a blistering start to January, says Harvey Jones.

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Spirax Group (LSE: SPX) has never been a headline grabber, but this overlooked UK income share is in the spotlight today. 

The FTSE 100 stock has climbed 21% since the start of the year, making it the third-best performer on the blue-chip index. Given its recent volatility the rally is a welcome surprise.

The Spirax share price still has some way to go. Over 12 months it’s down 18%, while over three years it has slumped 35%. So why the sudden jump?

A key reason seems to be fresh optimism around Chinese stimulus efforts. Spirax specialises in niche industrial and commercial steam systems, and China is a crucial market. With signs that Beijing could ramp up support for its economy, investors may be betting on a recovery in demand for Spirax’s products.

Personally, I’m a little sceptical. One Chinese stimulus package after another has fallen short. Although this week’s DeepSeek shock shows we shouldn’t underestimate the country’s prospects.

The shares finally leap

Another major catalyst came from broker Jefferies, which upgraded its rating on Spirax to a Buy on 20 January. 

This formed part of its annual review of the UK industrials sector, where it downgraded Smiths Group and XP Power, among others.

Jefferies said a much-anticipated sector recovery failed to materialise last year and 2025 doesn’t look much brighter, amid “limited positive momentum and plenty of uncertainty”. But it was more upbeat about Spirax, claiming it had now “been through the worst and can recover nicely over the next two to three years”.

That helped spark the January rally but Jefferies still didn’t include Spirax in its top picks. That probably put a lid on the rally too.

I wrote on 10 January that Spirax had completely flown under my radar. The global industrials slowdown had taken its toll, with falling Chinese demand hitting its Steam Thermal Solutions division.

Yet analysts were upbeat even then. The 17 brokers offering one-year forecasts produced a median target of 7,825p, up 18% from the then-price of 6,630p.

A true FTSE 100 dividend star

I was tempted but thought Spirax looked expensive with a price-to-earnings ratio of more than 21 times earnings. It’s pricier today, with January’s rally pushing its P/E beyond 26 times.

Where Spirax really scores is on income. This is a blue-blood Dividend Aristocrat, with 55 years of consecutive annual increases. 

However, the yield has slipped after the recent price surge, dropping to just 1.95%. That’s surprisingly low, given recent share price struggles. I guess we can rely on it to grow steadily, although there are no guarantees, even with Spirax.

It should fare better in 2025 as its more profitable end markets recover, but I still think better value exists for me elsewhere on the FTSE 100. Debt of £1bn is a little hefty given its £6bn market cap. 

It’s good to see Spirax build up a bit of steam but it doesn’t change my stance. At today’s valuation, I’m staying on the sidelines.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 UK shares that could soar if interest rates sprint lower!

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

My favourite FTSE dividend stock just jumped 17%! So why am I sad?

This investor has mixed feelings today as a quality dividend stock from the FTSE 250 surged higher in his portfolio.…

Read more »

Investing Articles

Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

Read more »

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Investing Articles

Is this my chance to buy Alphabet shares?

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy…

Read more »

Senior woman potting plant in garden at home
Investing Articles

£10k in savings? Here’s how an investor could aim for a monthly second income of £1,200

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio…

Read more »